Mon, Mar 2, 2015, 2:32 AM EST - U.S. Markets open in 6 hrs 58 mins

Recent

% | $
Quotes you view appear here for quick access.

Kinder Morgan Energy Partners, L.P. Message Board

stimulatemypackage 2 posts  |  Last Activity: Feb 27, 2015 11:50 PM Member since: Mar 12, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • stimulatemypackage by stimulatemypackage Feb 27, 2015 11:50 PM Flag

    From the DPRX silce deck:

    Mild DFI

    Currently no FDA approved product

    Incidence: Approximately 650,000 patients annually (US)

    Locilex ® could become the standard of care

  • Reply to

    CEMP is an Investment

    by itrizia Feb 27, 2015 10:09 AM
    stimulatemypackage stimulatemypackage Feb 27, 2015 11:24 PM Flag

    DPRX is in Phase III trials for diabetic foot ulcers

    NEW YORK, Feb. 25, 2015 /PRNewswire/ -- Dipexium Pharmaceuticals, Inc. (DPRX), today announced that its two pivotal Phase 3 clinical trials, known as OneStep-1 and OneStep-2, have passed the 25% enrollment milestone, in the aggregate, with each study having enrolled nearly the same number of patients.

    The OneStep Phase 3 clinical trials are being conducted under a Special Protocol Assessment (SPA) agreement from the Food and Drug Administration (FDA) for evaluation of Locilex® (pexiganan cream 0.8%), the Company's novel, broad-spectrum topical antibiotic peptide for the treatment of patients with mild infections of diabetic foot ulcers.

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.